Nathaniel Jonathan Berky: New Protein-Binding Insight May Transform Personalised IVF
Nathaniel Jonathan Berky, Venture Architect, shared a post on LinkedIn:
“This is an important advance for reproductive health.
Understanding fertilisation at this molecular-mechanical level brings us closer to a truly personalised IVF journey in which fit-for-purpose treatment (rather than ‘unexplained’) can be identified within a failed cycle.
If this protein-binding mechanism can be verified in the clinic, it could shorten the trial and error aspect of treatment, improve IVF success rates, and change how we screen patients to prepare them for a cycle.
Switzerland is well placed for this next stage: we have good research (Basel, ETH-Department of Biosystems Science and Engineering (D-BSSE)), the biotech translation capacity, and a patient group who would expect evidence-based care than just fertility standard protocols.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG